Department of General Surgery, Cleveland Clinic, Cleveland, OH, USA.
Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, USA.
Surg Endosc. 2019 Mar;33(3):773-781. doi: 10.1007/s00464-018-6342-6. Epub 2018 Jul 17.
Gastroparesis is a debilitating functional disorder of the stomach characterized by delayed gastric emptying absent an obstructive etiology. Surgical or endoscopic disruption of the pylorus has been utilized to treat this disease, but there is little evidence comparing laparoscopic pyloroplasty (LP) with endoscopic per-oral pyloromyotomy (POP). Herein we describe our experience at our institution using a propensity-matched cohort study to compare outcomes between these procedures.
All patients who underwent LP for the treatment of gastroparesis from October 2014 through September 2017 at our institution were retrospectively reviewed. Propensity scoring was used to match these patients 1:1 to patients undergoing POP during this time period based on gender, age, and etiology of gastroparesis. Symptom scores using the Gastroparesis Cardinal Symptom Index (GCSI), scintigraphic gastric emptying studies (GES), and perioperative outcomes were compared between matched cohorts. Thirty patients underwent LP for gastroparesis during the study period which were matched 1:1 with patients undergoing POP. The etiology of gastroparesis was 63.3% idiopathic (n = 19), 20.0% post-surgical (n = 6), and 16.7% diabetic (n = 5) in both cohorts.
Patients who underwent LP had a longer average length of stay (4.6 vs. 1.4 days, p = 0.003), operative time (99.3 vs. 33.9 min, p < 0.001), and estimated blood loss (12.9 vs. 0.4 mL, p < 0.001). There were more complications in the LP cohort (16.7 vs. 3.3%, p = 0.086), which included surgical site infection (6.7 vs. 0%, p = 0.153), pneumonia (6.7 vs. 0.0%, p = 0.153), and unplanned ICU admission (10.0 vs. 0.0%, p = 0.078). LP and POP both resulted in similar, significant improvements in both in GCSI scores and objective gastric emptying.
Per-oral endoscopic pyloromyotomy (POP) is safe and effective for the treatment of medical refractory gastroparesis. POP has less perioperative morbidity compared to LP with comparative functional outcomes.
胃轻瘫是一种以胃排空延迟为特征的、使人虚弱的胃部功能性障碍,且无梗阻性病因。外科或内镜破坏幽门已被用于治疗这种疾病,但很少有证据比较腹腔镜幽门成形术(LP)与经口内镜下幽门肌切开术(POP)。在此,我们通过倾向评分匹配队列研究来描述我们在机构中的经验,以比较这两种手术的结果。
回顾性分析了 2014 年 10 月至 2017 年 9 月期间在我院接受 LP 治疗胃轻瘫的所有患者。根据性别、年龄和胃轻瘫病因,使用倾向评分将这些患者与同期接受 POP 的患者进行 1:1 匹配。使用胃轻瘫卡特尔症状指数(GCSI)、闪烁胃排空研究(GES)和围手术期结果比较匹配队列的症状评分。在此期间,有 30 例患者因胃轻瘫接受 LP,与同期接受 POP 的患者进行 1:1 匹配。两组胃轻瘫的病因分别为 63.3%(n=19)为特发性,20.0%(n=6)为手术后,16.7%(n=5)为糖尿病。
LP 组的平均住院时间(4.6 天比 1.4 天,p=0.003)、手术时间(99.3 分钟比 33.9 分钟,p<0.001)和估计出血量(12.9 毫升比 0.4 毫升,p<0.001)均较长。LP 组的并发症较多(16.7%比 3.3%,p=0.086),包括手术部位感染(6.7%比 0%,p=0.153)、肺炎(6.7%比 0%,p=0.153)和计划外 ICU 入院(10.0%比 0.0%,p=0.078)。LP 和 POP 均使 GCSI 评分和客观胃排空均有显著改善。
经口内镜下幽门肌切开术(POP)是治疗药物难治性胃轻瘫的安全有效的方法。与 LP 相比,POP 的围手术期发病率较低,功能结局相当。